| protein
| interacting with SOX9 in the differentiation of endocardial cushion cells |
|
interacting with SP7 to control osteoblastic bone formation |
|
direct transcriptional target of RCAN1 within the endocardium during a critical window of heart valve formation |
|
interacting with ATP6V0D2 (NFATC1/ATP6V0D2 and dendritic cell-specific transmembrane protein signaling axis plays a key role in the osteoclast multinucleation process, which is essential for efficient bone resorption)  |
|
OSCAR is an important costimulatory receptor for osteoclast differentiation through activation of NFATC1 |
|
demethylation of H3K27me3 in the NFATC1 gene locus by KDM6B plays a critical role in TNFSF11-induced osteoclast differentiation |
|
GPC6 is a novel NFATC1, NFATC2, NFATC3, NFATC4 target gene in breast cancer cells that promotes invasive migration through WNT5A signalling |
|
both FOXP3 and SIVA1 function as negative regulators of IL2 gene expression in Treg cells, via suppression of NFATC1 by FOXP3 and of NFKB1 by both FOXP3 and SIVA1 |
|
IL2 upregulates CD86 expression on human CD4(+) and CD8(+) T cells via a receptor-dependent mechanism that involves the NFATC1 and mammalian target of rapamycin pathways |
|
AKT2 a negative regulator of NFATC1 activation through its ability to inhibit calcium mobilization from the ER |
|
KDM8 is a post-translational co-repressor for NFATC1 that attenuates osteoclastogenesis |
|
synthesis of FN1 is mediated by a transcriptional complex consisting of NFATC1, SP7 and FOS |
|
upon TNFSF11 activation, HDAC7 suppresses NFATC1 and prevents CTNNB1 down-regulation, thereby blocking osteoclast differentiation |
|
SERPINA12 likely downregulates osteoclastogenesis in part by inhibiting expression of the transcription factor NFATC1 |
|
mediates RHOA-induced FN1 upregulation in glomerular podocytes |
|
FAM102A plays a critical role in TNFRSF11A-induced osteoclast differentiation, and its role may be closely related to the induction of NFATC1 |
|
autocrine/paracrine role for RARRES2 in regulating osteoclast differentiation of hematopoietic stem cell (HSC) through modulating intracellular calcium and NFATC1 expression/activation |
|
NFATC1 sequestering the SMAD3 prevents the proteasome mediated degradation of SKIL and SKIL has a role on the regulation of MMP2, MMP9 activity |
|
ASIC1-mediated calcium entry plays a critical role in osteoclastogenesis by regulating activation of the NFATC1 |
|
ETS1 promotes the expression of IL2 by modulating the activity of NFATC1 |
|
NFATC1-mediated transcription regulates UTRN expression and FHL1 which promotes muscle hypertrophy, is a transcriptional activator of NFATC1 |
|
GRK5-mediated pathological cardiac hypertrophy involves the activation of NFATC1 because GRK5 causes enhancement of NFATC1-mediated hypertrophic gene transcription |
|
BSG plays a critical role in the differentiation and function of osteoclasts by upregulating NFATC1 through the autoamplification of its expression in osteoclastogenesis |
|
TNFSF11-induced LDHA, LDHB activation stimulates glycolytic and mitochondrial respiratory metabolism, facilitating mature osteoclast formation via osteoclast precursor fusion and NFATC1 signaling |
|
IKBKE promotes NFATC1 phosphorylation and inhibits T cell responses, identifying IKBKE as a crucial negative regulator of T cell activation |
|
DYRK1A is a positive kinase in regulation of NFATC1 |
|
biphasic roles of MTOR in osteoclastogenesis, dosage-dependent effects of rapamycin on bone, and a calcineurin-MTOR-NFATC1 phosphorylation-regulatory signaling cascade |
|
STAT3 could drive the transcription of NFATC1 by binding to its promoter |
|
DYRK1A activates NFATC1 to increase glioblastoma migration |
|
GAP43 attenuated podocyte injury by inhibiting calcineurin/NFATC1 signaling |
|
likely ESR1 interacts with NFATC1 to repress WNT5B protein expression |
|
activation of NFATC1 represses osteoblastogenesis by activating WNT5B expression |
